Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

st jude medical australia pty ltd -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

st jude medical australia pty ltd -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the ellipse dr cd2377-36c is a dual chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features an is-1/df-1 device header and parylene coating. the ellipse dr cd2377-36c is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the ellipse dr cd2377-36qc is a dual chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features a df4 device header and parylene coating. the ellipse dr cd2377-36qc is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af. this device is mri conditional.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the ellipse vr cd1377-36c is a single chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features an is-1/df-1 device header and parylene coating. the ellipse vr cd1377-36c is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the ellipse vr cd1377-36qc is a single chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features a df4 device header and parylene coating. the ellipse vr cd1377-36qc is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af. this device is mri conditional.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the fortify assura dr cd2359-40c is a dual chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features an is-1/df-1 device header and parylene coating. the fortify assura dr cd2359-40c is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the fortify assura dr cd2359-40qc is a dual chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features a df4 device header and parylene coating. the fortify assura dr cd2359-40qc is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af. this device is mri conditional.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - fortify assura vr cd1359-40c is a single chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features an is-1/df-1 device header and parylene coating. the fortify assura vr cd1359-40c is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 35852 - defibrillator, implantable, automatic - the fortify assura vr cd1359-40qc is a single chamber implantable cardioverter defibrillator (icd) with rf telemetry and it monitors and regulates a patient's heart rate by providing ventricular tachyarrhythmia therapy. it features a df4 device header and parylene coating. the fortify assura vr cd1359-40qc is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. also at/af detection algorithm is indicated for detecting atrial tachyarrhythmias which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of af. this device is mri conditional.